共 50 条
- [1] Safety, Tolerability, and Pharmacokinetics of NIM-1324 an Oral LANCL2 Agonist in a Randomized, Double-Blind, Placebo-Controlled Phase I Clinical TrialCTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2025, 18 (01):Leber, AndrewHontecillas, RaquelTubau-Juni, NuriaBassaganya-Riera, Josep
- [2] SAFETY AND TOLERABILITY OF BT-11, A GUT-RESTRICTED LANCL2 AGONIST, IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE I STUDY IN NORMAL HEALTHY VOLUNTEERSGASTROENTEROLOGY, 2019, 156 (06) : S1112 - S1112Leber, AndrewHontecillas, RaquelZoccoli-Rodriguez, VictoriaColombel, Jean FredericChauhan, JyotiBassaganya-Riera, Josep
- [3] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies of the Safety, Tolerability and Pharmacokinetics of Naldemedine in Healthy VolunteersGASTROENTEROLOGY, 2016, 150 (04) : S537 - S538Fukumura, KazuyaYokota, TakaakiBaba, YukoCamilo, JuanFerreira, Arjona
- [4] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy VolunteersCLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (05): : 474 - 483Fukumura, KazuyaYokota, TakaakiBaba, YukoFerreira, Juan Camilo Arjona
- [5] Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: A randomized, double-blind, placebo-controlled studyJOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (06) : 832 - 842Kahn, Rene S.Schulz, S. CharlesPalazov, Veselin D.Reyes, Efren B.Brecher, MartinSvensson, OlaAndersson, Henrik M.Meulien, Didier
- [6] Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trialJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (01) : 164 - +Zuraw, BruceLumry, William R.Johnston, Douglas T.Aygoren-Pursun, EmelBanerji, AleenaBernstein, Jonathan A.Christiansen, Sandra C.Jacobs, Joshua S.Sitz, Karl V.Gower, Richard G.Gagnon, RemiWedner, H. JamesKinaciyan, TamarHakl, RomanHanzlikova, JanaAnderson, John T.McNeil, Donald L.Fritz, Stephen B.Yang, William H.Tachdjian, RaffiBusse, Paula J.Craig, Timothy J.Li, H. HenryFarkas, HenrietteBest, Jessica M.Clemons, DesireeCornpropst, MelanieDobo, Sylvia M.Iocca, Heather A.Kargl, DeborahNagy, EnikoMurray, Sharon C.Collis, PhilSheridan, William P.Maurer, MarcusRiedl, Marc A.
- [7] Efficacy and safety of once-daily carvedilol in patients with atrial fibrillation: A randomized, double-blind, placebo-controlled trialHEART RHYTHM, 2024, 21 (10) : 2051 - 2052Choi, Jong-IlPark, Yae MinOh, Yong-SeogKim, Jin-BaeHan, SeongwookPark, Jong-SungOn, Young KeunChoi, Kee-JoonHwang, Gyo-SeungLee, Moon-HyoungShin, Dong-GuKim, Nam-HoKim, Dae-KyeongNamgung, JuneKim, Dae-HyeokPark, Hyung-WookPark, Hwan-CheolChoi, Eue-KeunRhee, Kyoung SukShin, Seung YongKim, Young-Hoon
- [8] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Ascending Multiple Oral Doses of CC 930 in Healthy VolunteersJOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1343 - 1343Kong, LinghuiYe, YingLiu, LiangangReyes, JosephineWan, YuntaoWu, AnfanLau, HenryLaskin, Oscar
- [9] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF SINGLE- AND MULTIPLE-DOSE ONCE-DAILY BARICITINIB IN CHINESE HEALTHY VOLUNTEERS - A RANDOMIZED PLACEBO-CONTROLLED STUDYANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 378 - 378Zhao, XiaPayne, ChristopherWang, FengCui, Yiming
- [10] Safety, Tolerability, and Pharmacokinetics of Kukoamine B in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Phase I StudyADVANCES IN THERAPY, 2023, 40 (07) : 3186 - 3198Zhao, QianLiu, HongzhongWang, ZhenleiWang, TengCui, ChengWang, HuanhuanLi, LiliZhong, WenJiang, JiDong, KaiChen, ShuaiJin, ChunyanHu, Pei